- This event has passed.
Bench to BARDA MedTech Series – Funding for Startups
This program is a series of 6 panel discussions with industry and government partners, focused on providing guidance and insight into how innovators can take their solution from the benchtop to the Biomedical Advanced Research & Development Authority (BARDA). BARDA is an entity within the Department of Health & Human Services that advances innovations tackling some of our nation’s greatest health security threats. This program is a collaborative effort between incubators and accelerators who are partnered with them through their Division of Research, Innovation & Ventures (DRIVe). Each event will have its own specific focus, while contributing to a sequential flow for the series. Experts with specific backgrounds will be asked to help provide an overview of key resources available to innovators to help fund and advance their solution from early stages of development through late stages, as well as provide guidance on how to navigate the funding opportunities within BARDA and BARDA DRIVe.
This event is a collaborative event between the following BARDA accelerators and incubators:
First Flight Venture Center
New Orleans BioInnovation Center
New York State Center for Biotechnology
University City Science Center
University of Missouri
Attend this series if you are an early-stage startup who would benefit from expert insight and knowledge about the resources available to you throughout your commercialization journey! This series will give you a better understanding of what opportunities are not only out there, but also best for you depending on your current technology-readiness-level, where and when to engage with the right government partners to advance your solution, and insight into obtaining funding at all stages of development.
Timeline and Summary
Panel Discussion 1: BARDA Accelerator Network – Opportunities for Early-Stage Startups
June 14th from 12:00PM – 1:30PM EST
The Biomedical Advanced Research and Development Authority (BARDA) has partnered with 13 incubators and accelerators across the United States to help provide crucial resources to early-stage innovators looking to address our biggest health security threats with innovative solutions. These centers work together as a collaborative network to help DRIVe innovation from the benchtop to BARDA. During this event you will hear from key players in the network who will share more about the various resources and funding opportunities they have available to early-stage innovators to help get their solutions to more advanced stages, there will also be time allotted for Q&A. Join us to learn more about what the BARDA Accelerator Network has to offer.
Panel Discussion 2: I-Corps, NSF and NIH REACH – Opportunities for Translational Research
June 17th from 12:00PM – 1:30PM EST
A variety of federally funded programs are in place to assist early-stage inventors in successfully making the transition into entrepreneurship. The National Science Foundation (NSF) supports disruptive innovation with the non-dilutive SBIR/STTR program. As an earlier-phase extension of that support, the NSF Innovation Corps (I-Corps) assists nascent groups in defining the value of their invention to society by engaging in the customer discovery process. During this event we will hear from I-Corps and NSF representatives, and from the CEOs of startup companies who have participated in I-Corps programs and subsequently gone on to receive NSF awards. Speakers will then discuss their experiences together and take your questions. Join us to learn more about how the NSF pathway can advance your innovation.
Panel Discussion 3: NIH SBIR/STTR & RADx
June 21st from 12:00PM – 1:30PM EST
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR), collectively the Small Business Programs, are also known as America’s Seed Fund. By setting aside more than $1.2 billion from its Research & Development Funding specifically for Small Business Programs, the NIH provides support to early stage small businesses throughout the nation. In 2020, the NIH expanded their support of early stage medical innovation by launching the Rapid Acceleration of Diagnostics (RADx®) initiative to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing. During this event, you will hear from agency officials at NIH as well as entrepreneurs and researchers that have received funding through these mechanisms. Join us to learn more about accessing these resources for your medical innovation.
Panel Discussion 4: BARDA DRIVe EZ-BAA – Overview & Funding Opportunities
June 24th from 12:00PM – 1:30PM EST
The Easy Broad Agency Announcement (EZ-BAA) is a contracting mechanism that allows BARDA to partner with early-stage product developers on smaller scale R&D projects. The EZ-BAA provides up to $750K in non-dilutive funds to accelerate innovations and improve the availability of transformative products and technologies to protect Americans from natural and intentional health security threats. During this event you will learn about the EZ-BAA and its process along with how to submit a complete abstract for the award. You will also learn about how the EZ-BAA differs from the BAA and which pathway is best suited for your company. Come learn best practices for EZ-BAA funding opportunities and hear from past EZ-BAA awardees.
Panel Discussion 5: BARDA Broad Agency Announcement (BAA)
June 28th from 12:00PM – 1:30PM EST
The Broad Agency Announcement (BAA) is a contracting mechanism that is often used by federal agencies for the advancement of scientific studies and experimentation directed towards advancing the state-of-the-art. The BAA funding mechanism is used by BARDA to fund later-stage advanced research and development. There are a number of criteria that need to be met when completing a BAA application and leaders from across BARDA will discuss the various components and best practices for companies looking to apply for BAA funding at BARDA.
Panel Discussion 6: Institutional Capital (VC, CVC)
July 1st from 12:00PM – 1:30PM EST
Venture Capital is a form of private equity-based financing (including equity financing, convertible notes, and/or warrants) that invests in innovative promising technology in the early stages of development. The Biomedical Advanced Research and Development Authority (BARDA) works with the venture capital community to invest in promising products and technologies, driving them to the marketplace to transform and enhance national health security. During this event you will hear from BARDA and non-BARDA VC executives who will give insight on how to appeal to and work with VC investors to help bring products and technologies to market. Join us to learn more about Venture Capital investing!